1. Nitric oxide: physiology, pathophysiology and pharmacology;Moncada, S.; Palmer, R.M.J.; Higgs, E.A.;Pharmacol Rev,1991
2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor;Palmer, R.M.J.; Ferrige, A.G.; Moncada, S.;Nature (Lond),1987
3. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor;Archer, S.L.; Tobins, J.P.; Raij, L.; Weir, E.K.;Biochem Biophys Res Commun,1989
4. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease;Dinh-Xuan, A.T.; Higenbottam, T.W.; Clelland, C.A.; PepkeZaba, J.; Cremona, G.; Butt, A.Y.;N Engl 7 Med,1991
5. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension;Pepke-Zaba, J.; Higenbottam, T.W.; Dinh-Xuan, A.T.; Stone, D.; Wallwork, J.;Lancet,1991